A Clinical Trial of SIBP-A16 Injection in Healthy Adults
Trial Parameters
Brief Summary
This study is a randomized, double-blind, placebo/positive control Phase Ia clinical trial evaluating the safety, tolerability, and pharmacokinetics of SIBP-A16 injection in healthy adults
Eligibility Criteria
Inclusion Criteria: * Healthy individuals aged 18 to 45 on the day of enrollment, regardless of gender. * Male body weight ≥ 50.0 kg, female body weight ≥ 45.0 kg, BMI between 19.0 and 27.0 kg/m2 (including critical values). * Screening period physical examination, vital sign examination, 12 lead electrocardiogram, chest X-ray or clinical laboratory examination, and other auxiliary examination results show normal or abnormal without clinical significance as judged by the researcher. * Individuals who voluntarily participate in clinical trials and sign informed consent forms. * Individuals are able to communicate well with the researchers and understand and comply with the requirements of this study. Exclusion Criteria: * Known to have a history of serious clinical diseases such as mental system, circulatory system, endocrine system, digestive system, respiratory system, hematological and metabolic abnormalities, or any other diseases that can interfere with the test results. * Individu